Results 1 to 10 of about 4,345 (184)

Left Atrial Appendage Closure in Patients Refusing Oral Anticoagulation: The LAAC‐REFUSAL Study [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The benefit of left atrial appendage closure (LAAC) in patients refusing oral anticoagulation (OAC) despite medical recommendations is unknown. We aim to assess the efficacy and the safety of LAAC in patients refusing OAC.
Roberto Galea, Tommaso Bini, Kasper Korsholm, Alexander Sedaghat, Adel Aminian, Vivian Vij, Juan Perich Krsnik, Konstantina Chalkou, Georgios Siontis, Laurent Roten, Jens Erik Nielsen‐Kudsk, Lorenz Räber   +11 more
doaj   +3 more sources

Impact of Peridevice Leak on Clinical Outcomes After Left Atrial Appendage Closure: The OCEAN‐LAAC Registry [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The impact of peridevice leak (PDL) at device implantation on clinical outcomes after percutaneous left atrial appendage closure (LAAC) is unknown.
Tetsuya Saito, Hikaru Tsuruta, Akiyoshi Kajino, Juri Iwata, Shingo Sakata, Toshinobu Ryuzaki, Mitsuru Sago, Shuhei Tanaka, Ryuki Chatani, Daisuke Hachinohe, Toru Naganuma, Yohei Ohno, Tomoyuki Tani, Hideharu Okamatsu, Kazuki Mizutani, Yusuke Watanabe, Masaki Izumo, Mike Saji, Shingo Mizuno, Hiroshi Ueno, Shunsuke Kubo, Shinichi Shirai, Masaki Nakashima, Masahiko Asami, Masanori Yamamoto, Masaki Ieda, Kentaro Hayashida   +26 more
doaj   +4 more sources

Rationale and design of a randomized clinical trial evaluating the efficacy of mechanical neuroprotection in reducing the risk of silent brain infarcts associated with percutaneous left atrial appendage closure: study protocol for a LAAC-SBI trial [PDF]

Trials, 2023
Background Left atrial appendage closure (LAAC) procedures prevent cardioembolic stroke in patients with atrial fibrillation who have contraindications to oral anticoagulant medications.
Witold Streb, Anetta Lasek-Bal, Katarzyna Mitręga, Jacek Kowalczyk, Tomasz Podolecki, Wiktoria Kowalska, Anna Olma, Agata Sobczyk, Zbigniew Kalarus   +8 more
doaj   +4 more sources

Risk Factors and Outcomes of AKI after LAAC Operation: A Single-Center Observational Study from Mainland China [PDF]

Reviews in Cardiovascular Medicine, 2022
Background: This study aimed to investigate the predictors and prognosis of acute kidney injury (AKI) occurrence among Chinese patients following left atrial appendage closure (LAAC).
Lei Zhang, Jiarui Xu, Xiaoye Li, Xiaochun Zhang, Wenzhi Pan, Lihua Guan, Xiaoqiang Ding, Daxin Zhou, Junbo Ge   +8 more
doaj   +2 more sources

Comparison of oral anticoagulation and antiplatelet therapy during the midperiod after percutaneous left atrial appendage closure [PDF]

Frontiers in Cardiovascular Medicine
Background and aimThere is a lack of evidence comparing anticoagulation and antiplatelet therapy during the midperiod time after left atrial appendage closure (LAAC) in clinical practice (the “early period” is defined as “45 days” after LAAC for a single
Chang-Yi Li, Lu Zhou, Jing-Rui Zhang, Li-Hong Huang, Li-Zhu Guo, Song-Nan Li, Cai-Hua Sang, De-Yong Long, Jian-Zeng Dong   +8 more
doaj   +2 more sources

Long-term outcomes of left atrial appendage closure techniques on stroke prevention of recurrent atrial fibrillation patients: epicardial excision versus percutaneous occlusion [PDF]

Frontiers in Cardiovascular Medicine
ObjectiveThis study aimed to compare the efficacy of left atrial appendage closure performed by excision (LAAC-EE) vs. occlusion (LAAC-PO) for stroke prevention in patients with recurrent atrial fibrillation undergoing radiofrequency ablation.MethodsIn ...
Adnan Abibe Goia, Meng Xu, Hu Qiuming
doaj   +2 more sources

Left Atrial Appendage Closure in Patients with Atrial Fibrillation and Intermediate-to-Borderline High Cardiovascular Risk: A Retrospective Propensity Match Cohort Study [PDF]

Journal of Cardiovascular Development and Disease
Background and objective: Evidence of percutaneous left atrial appendage closure (LAAC) and oral anticoagulants (OACs) in non-valvular atrial fibrillation (NVAF) patients with intermediate-to-borderline high stroke risk is scarce. We aimed to compare the
Jiayi Liu, Ningjing Qian, Ying Gao, Junyan Jin, Bingqi Wang, Muhua Luo, Yaping Wang   +6 more
doaj   +2 more sources

Stroke prevention in nonvalvular atrial fibrillation: Thoracoscopic left atrial appendage closure with or without surgical ablationCentral MessagePerspective [PDF]

JTCVS Techniques
Objectives: Totally thoracoscopic left atrial appendage closure (TT-LAAC) with or without the MAZE procedure is an LAA management technique that prevents cardioembolic events by closing the LAA in patients with atrial fibrillation (AF).
Hiroshi Ito, MD, Hiroshi Kurazumi, MD, Soichi Ike, MD, Masaya Takahashi, MD, Takahiro Mizoguchi, MD, Kimikazu Hamano, MD   +5 more
doaj   +2 more sources

Management of device embolization following left atrial appendage closure: Two cases and a review of the literature [PDF]

Journal of Arrhythmia
Objectives Device embolization (DE) following left atrial appendage closure (LAAC) is a severe but uncommon complication, and limited data address optimal management strategies for this condition. This review presents two cases of device embolization (DE)
Ahmet Kivrak, Ahmet Hakan Ates, Ugur Canpolat, Mert Dogan, Cem Coteli, Hikmet Yorgun, Mehmet Levent Sahiner, Ergun Barıs Kaya, Kudret Aytemir   +8 more
doaj   +2 more sources

Antithrombotic Therapy after Percutaneous Left Atrial Appendage Closure: Evidence, Challenges and Future Directions

Reviews in Cardiovascular Medicine, 2023
Percutaneous left atrial appendage closure (LAAC) has been established in clinical practice as an attractive alternative to oral anticoagulation for preventing stroke in patients with atrial fibrillation and high bleeding risk.
Roberto Galea, Lorenz Räber
doaj   +1 more source